Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;25(6):435-449.
doi: 10.1080/14728222.2021.1952987. Epub 2021 Jul 15.

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

James Michael Brimson  1   2 , Mani Iyer Prasanth  1   2 , Dicson Sheeja Malar  1   2 , Sirikalaya Brimson  3 , Premrutai Thitilertdecha  4 , Tewin Tencomnao  1   2
Affiliations
Review

Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy

James Michael Brimson et al. Expert Opin Ther Targets. 2021 Jun.

Abstract

Introduction: Despite the availability of new vaccines for SARS-CoV-2, there has been slow uptake and problems with supply in some parts of the world. Hence, there is still a necessity for drugs that can prevent hospitalization of patients and reduce the strain on health care systems. Drugs with sigma affinity potentially provide protection against the most severe symptoms of SARS-COV-2 and could prevent mortality via interactions with the sigma-1 receptor.Areas covered: This review examines the role of the sigma-1 receptor and autophagy in SARS-CoV-2 infections and how they may be linked. The authors reveal how sigma ligands may reduce the symptoms, complications, and deaths resulting from SARS-CoV-2 and offer insights on those patient cohorts that may benefit most from these drugs.Expert opinion: Drugs with sigma affinity potentially offer protection against the most severe symptoms of SARS-CoV-2 via interactions with the sigma-1 receptor. Agonists of the sigma-1 receptor may provide protection of the mitochondria, activate mitophagy to remove damaged and leaking mitochondria, prevent ER stress, manage calcium ion transport, and induce autophagy to prevent cell death in response to infection.

Keywords: COVID-19; SARS-CoV-2; autophagy; chlorpromazine; critical care; donepezil; fluoxetine; fluvoxamine; long COVID; sigma-1.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The structures of various compounds that have activities related to the sigma-1 receptor
See this image and copyright information in PMC

References

    1. Dodds K, Broto VC, Detterbeck K, et al. The COVID-19 pandemic: territorial, political and governance dimensions of the crisis. Territory, Politics, Governance. 2020. May 26;8(3):289–298.
    1. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020. September 01;19(9):767–783. - PMC - PubMed
    1. Garg RK, Paliwal VK, Gupta A.. Encephalopathy in patients with COVID-19: a review. J Med Virol. 2021;93(1):206–222. - PubMed
    1. Tan L, Lin ZC, Ray J, et al. Neurological implications of COVID-19: a review of the science and clinical guidance. BMJ Neurol Open. 2020;2(2):e000101. - PMC - PubMed
    1. Taquet M, Geddes JR, Husain M, et al. 66-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5): 416–427. - PMC - PubMed

    2. •• Indication of the need for treatment with neuroprotective drugs in COVID 19 patients.

Publication types

LinkOut - more resources